Carisma Therapeutics to Present at Upcoming Healthcare Industry and Investor Conferences in April 2023

On April 6, 2023 Carisma Therapeutics Inc. (Nasdaq: CARM), a clinical stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, reported that the Company will participate at several conferences in April 2023 (Press release, Carisma Therapeutics, APR 6, 2023, View Source [SID1234629869]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Upcoming healthcare industry conferences include:

2023 Cell & Gene Meeting on the Med

Tom Wilton, Chief Business Officer, will give a corporate presentation.
Thursday, April 13, 2023 at 10:45 am CET
Barcelona, Spain
American Association for Cancer Research (AACR) (Free AACR Whitepaper) Annual Meeting 2023

Carisma will present three data abstracts during the meeting:
Macrophages engineered with cytokine switch receptors: Development of a modular platform for rebalancing inflammation in microenvironments;
A mesothelin targeting chimeric antigen receptor macrophage (CAR-M) for solid tumor immunotherapy: pre-clinical development of CT-1119; and
A Phase 1, First-in-Human study of autologous anti-HER2 CAR-M in participants with HER2 overexpressing solid tumors.
Friday, April 14 to Wednesday, April 19, 2023
Orlando, Florida
Upcoming investor conferences include:

Needham 22nd Annual Virtual Healthcare Conference

Steven Kelly, President and Chief Executive Officer, will participate in a fireside chat and will give a corporate presentation.
Thursday, April 20, 2023 at 12:45 pm EDT
Virtual
Register to view webcast here.
Chardan’s 7th Annual Genetic Medicines & Cell Therapy Manufacturing Summit

Steven Kelly, President and Chief Executive Officer, and Michael Klichinsky, PhD, Co-Founder and Chief Scientific Officer, will participate in a fireside chat.
Monday, April 24, 2023 at 11:00 am EDT
Virtual
Register to view webcast here.
A replay of webcasts, when available, will be posted and archived at the Company’s Investor Events webpage for a limited time following the event.